What is Salarius Pharmaceuticals Inc (SLRX) stock price today?

Salarius Pharmaceuticals Inc (SLRX) currently trades at $0.84 per share. The stock has a market capitalization of $4.92M and a P/E ratio of —x.

Is SLRX stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Salarius Pharmaceuticals Inc has a Smart Value Score of 21/100 (Grade F), resulting in a "Strong Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

SLRX

Salarius Pharmaceuticals Inc

NASDAQ: SLRX · HEALTHCARE · BIOTECHNOLOGY

$0.84

+29.23% today

Updated 2026-01-07

Market cap

$4.92M

P/E ratio

—

P/S ratio

18.12x

EPS (TTM)

$-24.24

Dividend yield

—

52W range

$1 – $25

Volume

2.4M

Market cap

$4.92M

P/E ratio

—

P/S ratio

18.12x

EPS (TTM)

$-24.24

Dividend yield

—

52W range

$1 – $25

Volume

2.4M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

3.7

Growth

5.0

Quality

C+

3.0

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →201 stocks currently score above 75

Price targets

Analyst target

$26.00

+2995.24%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

Insufficient data

Risks

- Thin margins at 0.00%

- Negative free cash flow $-1.65M

- Revenue declining -1.00% QoQ

Key financials

Revenue Net Income Free Cash Flow

Metric	2021	2022	2023	2024	TTM
Revenue	$1.84M	$0.00	$0.00	$0.00	$0.00
Net income	$-12.77M	$-31.61M	$-12.54M	$-5.58M	$-873467.00
EPS	—	—	—	—	$-24.24
Free cash flow	$-10.20M	$-19.10M	$-12.85M	$-4.53M	$-1.65M
Profit margin	-693.84%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
SLRX	$4.92M	21	3.7	3.0	5.0	5.0	—	Avoid
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Salarius Pharmaceuticals Inc trades at $0.84. Our Smart Value Score of 21/100 indicates the stock is weak.

Frequently asked questions

What is Salarius Pharmaceuticals Inc's stock price?

Salarius Pharmaceuticals Inc (SLRX) trades at $0.84.

Is Salarius Pharmaceuticals Inc overvalued?

Smart Value Score 21/100 (Grade F, Strong Sell).

What is the price target of Salarius Pharmaceuticals Inc (SLRX)?

The analyst target price is $26.00, representing +2995.2% upside from the current price of $0.84.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio18.12x

ROE-1.40%

Beta0.32

50D MA$0.82

200D MA$6.61

Shares out0.01B

Float0.01B

Short ratio—

Avg volume2.4M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

SLRX vs LLY →SLRX vs JNJ →SLRX vs ABBV →Stock screener →